These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

806 related items for PubMed ID: 16867163

  • 1. An update on the long-acting insulin analogue glargine.
    Thisted H, Johnsen SP, Rungby J.
    Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):1-11. PubMed ID: 16867163
    [Abstract] [Full Text] [Related]

  • 2. Insulin glargine (Lantus).
    Owens DR, Griffiths S.
    Int J Clin Pract; 2002 Jul; 56(6):460-6. PubMed ID: 12166545
    [Abstract] [Full Text] [Related]

  • 3. [Long-acting insulin analogs: progressing slowly].
    Holleman F, Hoekstra JB.
    Ned Tijdschr Geneeskd; 2004 Aug 21; 148(34):1668-9. PubMed ID: 15453117
    [Abstract] [Full Text] [Related]

  • 4. Insulin therapy in type 2 diabetes: role of the long-acting insulin glargine analogue.
    Yki-Järvinen H.
    Eur J Clin Invest; 2004 Jun 21; 34(6):410-6. PubMed ID: 15200492
    [Abstract] [Full Text] [Related]

  • 5. Insulin glargine: a long-acting insulin for diabetes mellitus.
    Garces K.
    Issues Emerg Health Technol; 2003 Nov 21; (52):1-4. PubMed ID: 14626260
    [Abstract] [Full Text] [Related]

  • 6. The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes.
    Baxter MA.
    Acta Diabetol; 2008 Dec 21; 45(4):253-68. PubMed ID: 18766296
    [Abstract] [Full Text] [Related]

  • 7. Lower severe hypoglycemia risk: insulin glargine versus NPH insulin in type 2 diabetes.
    Dailey G, Strange P.
    Am J Manag Care; 2008 Jan 21; 14(1):25-30. PubMed ID: 18197742
    [Abstract] [Full Text] [Related]

  • 8. Safety and efficacy of glargine compared with NPH insulin for the treatment of Type 2 diabetes: a meta-analysis of randomized controlled trials.
    Bazzano LA, Lee LJ, Shi L, Reynolds K, Jackson JA, Fonseca V.
    Diabet Med; 2008 Aug 21; 25(8):924-32. PubMed ID: 18959605
    [Abstract] [Full Text] [Related]

  • 9. Basal insulin switch from NPH to glargine in children and adolescents with type 1 diabetes.
    Päivärinta M, Tapanainen P, Veijola R.
    Pediatr Diabetes; 2008 Jun 21; 9(3 Pt 2):83-90. PubMed ID: 18221431
    [Abstract] [Full Text] [Related]

  • 10. Insulin detemir: new drug. A second long-acting insulin analogue: many uncertainties, few advantages.
    Prescrire Int; 2006 Oct 21; 15(85):163-7. PubMed ID: 17121210
    [Abstract] [Full Text] [Related]

  • 11. Long-acting insulin analogues versus NPH human insulin in type 2 diabetes: a meta-analysis.
    Monami M, Marchionni N, Mannucci E.
    Diabetes Res Clin Pract; 2008 Aug 21; 81(2):184-9. PubMed ID: 18495286
    [Abstract] [Full Text] [Related]

  • 12. Insulin analogues in the management of diabetes.
    Vázquez-Carrera M, Silvestre JS.
    Methods Find Exp Clin Pharmacol; 2004 Aug 21; 26(6):445-61. PubMed ID: 15349139
    [Abstract] [Full Text] [Related]

  • 13. Insulin detemir: a new basal insulin analogue.
    Soran H, Younis N.
    Diabetes Obes Metab; 2006 Jan 21; 8(1):26-30. PubMed ID: 16367879
    [Abstract] [Full Text] [Related]

  • 14. A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes.
    Marbury TC, Schwartz S, Rosenberg MA, Jariwala N, Becker RH, Johnston PS.
    Exp Clin Endocrinol Diabetes; 2008 May 21; 116(5):282-8. PubMed ID: 18484560
    [Abstract] [Full Text] [Related]

  • 15. A randomized pilot study in Type 1 diabetes complicated by severe hypoglycaemia, comparing rigorous hypoglycaemia avoidance with insulin analogue therapy, CSII or education alone.
    Thomas RM, Aldibbiat A, Griffin W, Cox MA, Leech NJ, Shaw JA.
    Diabet Med; 2007 Jul 21; 24(7):778-83. PubMed ID: 17535290
    [Abstract] [Full Text] [Related]

  • 16. Dosing of insulin glargine in the treatment of type 2 diabetes.
    Barnett A.
    Clin Ther; 2007 Jun 21; 29(6):987-99. PubMed ID: 17692716
    [Abstract] [Full Text] [Related]

  • 17. An overview of insulin glargine.
    Home PD, Ashwell SG.
    Diabetes Metab Res Rev; 2002 Jun 21; 18 Suppl 3():S57-63. PubMed ID: 12324987
    [Abstract] [Full Text] [Related]

  • 18. Optimizing glycemic control with insulin glargine.
    Williams JB.
    Diabetes Technol Ther; 2003 Jun 21; 5(3):471-3. PubMed ID: 12828834
    [No Abstract] [Full Text] [Related]

  • 19. Rational use of insulin analogues in the treatment of type 1 diabetes mellitus.
    Bolli GB.
    Pediatr Endocrinol Rev; 2003 Sep 21; 1(1):9-21. PubMed ID: 16437009
    [Abstract] [Full Text] [Related]

  • 20. Insulin glargine: long-acting basal insulin analog for improved metabolic control.
    Gerich JE.
    Curr Med Res Opin; 2004 Jan 21; 20(1):31-7. PubMed ID: 14741069
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.